Metformin was demonstrated to result in 2.935 kg weight loss after 6 months of treatment even when prescribed after the onset of metabolic dysregulation (55)
In the UK study from 2021, people taking semaglutide had greater improvements in physical capabilities and risk factors for heart disease and diabetes, including reductions in waist circumference, markers of inflammation, blood pressure and blood glucose levels
The drug is also being studied in MASH, a serious form of fatty liver disease linked to metabolic dysfunction
As research continues and peptides become more available to patients, ongoing education about these substances is essential
The results a median 26.5% scalp area regrowth with SALT scores dropping from 40% to 7.5% are among the most dramatic improvements reported in androgenetic alopecia research
[DOI] [PubMed] [Google Scholar] 57.Tobaldi E., Dovgan I., Mosser M., Becht J.M., Wagner A